Although targeted therapies and immunotherapy have improved survival outcomes in many patients with lung cancer, these therapies come at a cost, not only financially but also in terms of cumulative ...

In these divisive political times, it’s easy to get swept up in the chaos—scrolling through negative social media posts, clashing with bickering relatives, and keeping up with nonstop news alerts.

As I open my laptop in anticipation of another Friday deadline, the date tells me it’s time again for VALENTINE’S DAY?—oh no—the hype, opportunity, anticipation, stress, and expectations. How can a ...